secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001193125-26-131872
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences adopts 2026 bonus plan; raises CEO bonus target to 65%
---------------------------------------------------------------------------

- Compensation Committee approved 2026 Corporate Bonus Plan effective Jan 1, 2026 with corporate and individual performance objectives.
- CEO Jason Okazaki's bonus target increased from 60% to 65% of base salary via Amendment No. 1 to employment agreement.
- Bonus targets range: CEO up to 75%, other executives 30-55%, non-executives up to 28% of base salary.
- Bonuses range from 0 to 1.5 times target; payment expected in Q1 of following year, no later than March 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000119312526131872/0001193125-26-131872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000119312526131872/asmb-20260324.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-131872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer